172 related articles for article (PubMed ID: 10435804)
21. Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.
Folkert MR; Cohen GN; Wu AJ; Gerdes H; Schattner MA; Markowitz AJ; Ludwig E; Ilson DH; Bains MS; Zelefsky MJ; Goodman KA
Brachytherapy; 2013; 12(5):463-70. PubMed ID: 23434221
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
23. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA
Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139
[TBL] [Abstract][Full Text] [Related]
24. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
[TBL] [Abstract][Full Text] [Related]
25. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
26. Esophageal brachytherapy: Institut Gustave Roussy's experience.
Kissel M; Chirat E; Annede P; Burtin P; Fumagalli I; Bronsart E; Mignot F; Schernberg A; Dumas I; Haie-Meder C; Chargari C
Brachytherapy; 2020; 19(4):499-509. PubMed ID: 32444283
[TBL] [Abstract][Full Text] [Related]
27. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract][Full Text] [Related]
28. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
29. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
30. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
31. High dose rate endobronchial brachytherapy using a new applicator.
Nomoto Y; Shouji K; Toyota S; Sasaoka M; Murashima S; Ooi M; Takeda K; Nakagawa T
Radiother Oncol; 1997 Oct; 45(1):33-7. PubMed ID: 9364629
[TBL] [Abstract][Full Text] [Related]
32. Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus.
Hareyama M; Nishio M; Kagami Y; Narimatsu N; Saito A; Sakurai T
Int J Radiat Oncol Biol Phys; 1992; 24(2):235-40. PubMed ID: 1526861
[TBL] [Abstract][Full Text] [Related]
33. Modulation of toxicity following external beam irradiation preceded by high-dose rate brachytherapy in inoperable oesophageal cancer.
Taal BG; Aleman BM; Koning CC; Boot H
Eur J Cancer; 1996 Sep; 32A(10):1815-8. PubMed ID: 8983296
[TBL] [Abstract][Full Text] [Related]
34. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
35. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
36. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
37. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
38. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
39. Esophageal ulceration induced by intracavitary irradiation for esophageal carcinoma.
Hishikawa Y; Tanaka S; Miura T
AJR Am J Roentgenol; 1984 Aug; 143(2):269-73. PubMed ID: 6611054
[TBL] [Abstract][Full Text] [Related]
40. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
Sur RK; Donde B; Levin VC; Mannell A
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
